|
Pt. I: Foundations and Issues
1. History of Tumescent Liposuction
2. Two Standards of Care for Liposuction
3. Ethical Considerations
4. Educational and Clinical Qualifications
5. Problems in Reporting Liposuction Deaths
Pt. II: Pathophysiology and Complications
6. Clinical Biostatistics of Safety
7. Risks of Systemic Anesthesia
8. Miscellaneous Complications
9. Superwet Liposuction and Pulmonary Edema
10. Thrombosis and Embolism
11. Postliposuction Edema
12. Infections
13. Hypothermia and Cryoanesthesia
14. Perioperative Bleeding Disorders
15. Maximum Safe Dose of Liposuction
Pt. III: Clinical Pharmacology
16. Pharmacology of Tumescent Technique
17. Pharmacology of Lidocaine
18. Cytochrome P450 3A4 and Lidocaine Metabolism
19. Pharmacokinetics of Tumescent Lidocaine
20. Lidocaine Toxicity and Drug Interactions
21. Maximum Recommended Dosage of Tumescent Lidocaine
22. Bupivacaine, Prilocaine, and Ropivacaine
23. Tumescent Formulations
24. Ancillary Pharmacology
Pt. IV: Fundamental Aspects of Tumescent Liposuction
25. Subcutaneous Fat: Anatomy and Histology
26. Tumescent Infiltration Technique
27. Microcannulas
28. Surgical Technique: Microcannular Tumescent Liposuction
29. Critique of Ultrasonic Liposuction
30. Postliposuction Care: Open Drainage and Bimodal Compression
Pt. V: Tumescent Liposuction by Area
31. Abdomen
32. Lateral Thighs
33. Female Hips and Back and Male Flanks
34. Medial Thighs, Knees, and Anterior Thighs
35. Chin, Cheeks and Jowls
36. Buttocks
37. Male Breasts
38. Female Breasts
39. Arms
40. Female Legs and Ankles
App: Patient Forms
|
